Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Launay-Vacher

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2013
Cancer and the kidney: individualizing dosage according to renal functionV Launay-Vacher
Nephron|December 22, 2000
Dosage of lamivudine in a haemodialysis patientH Izzedine, V Launay-Vacher, G Deray
La Revue De Medecine Interne|March 24, 2009
[Osteonecrosis of the jaw and bisphosphonates: current data and perspectives]J Gligorov, V Launay-Vacher, I Debrix
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2001
Pharmacokinetics of ritonavir and nevirapine in peritoneal dialysisH Izzedine, V Launay-Vacher, G Deray
Nephrologie|October 1, 2004
[Drug-induced nephrotoxicity. Bibliography from January to December 2003]S Karie, V Launay-Vacher, G Deray
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2012
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroadsF Scotté, J B Rey, V Launay-Vacher
Cancer Chemotherapy and Pharmacology|February 1, 2015
Intermittent dosing of aromatase inhibitors (AI) to improve tolerance in postmenopausal women: a rationale for future clinical studiesR Salmon, J B Rey, V Launay-Vacher
Kidney International|September 5, 2001
An appraisal of antiretroviral drugs in hemodialysisH Izzedine, V Launay-Vacher, A Baumelou, et al.
The American Journal of Gastroenterology|November 28, 2001
Acute pancreatitis induced by isoniazidH Izzedine, V Launay-Vacher, T Storme, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2001
[Pharmacokinetic changes in renal failure]V Launay-Vacher, T Storme, H Izzedine, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2013
Cancer and the kidney: individualizing dosage according to renal functionV Launay-Vacher
Nephron|December 22, 2000
Dosage of lamivudine in a haemodialysis patientH Izzedine, V Launay-Vacher, G Deray
La Revue De Medecine Interne|March 24, 2009
[Osteonecrosis of the jaw and bisphosphonates: current data and perspectives]J Gligorov, V Launay-Vacher, I Debrix
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2001
Pharmacokinetics of ritonavir and nevirapine in peritoneal dialysisH Izzedine, V Launay-Vacher, G Deray
Nephrologie|October 1, 2004
[Drug-induced nephrotoxicity. Bibliography from January to December 2003]S Karie, V Launay-Vacher, G Deray
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2012
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroadsF Scotté, J B Rey, V Launay-Vacher
Cancer Chemotherapy and Pharmacology|February 1, 2015
Intermittent dosing of aromatase inhibitors (AI) to improve tolerance in postmenopausal women: a rationale for future clinical studiesR Salmon, J B Rey, V Launay-Vacher
Kidney International|September 5, 2001
An appraisal of antiretroviral drugs in hemodialysisH Izzedine, V Launay-Vacher, A Baumelou, et al.
The American Journal of Gastroenterology|November 28, 2001
Acute pancreatitis induced by isoniazidH Izzedine, V Launay-Vacher, T Storme, et al.
Presse Medicale (Paris, France : 1983)|April 25, 2001
[Pharmacokinetic changes in renal failure]V Launay-Vacher, T Storme, H Izzedine, et al.
Pageof 6